top of page
Book Pages

Publications (2000-2004)

2004

  1. Sun R.W., Yu W.Y., Sun H.Z., Che C.M. (2004) “In vitro inhibition of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase by gold(III) porphyrins” ChemBioChem, 5(9), 1293-1298. doi: 10.1002/cbic.200300773.

  2. Sun X., Sun H.Z., Ge R., Richter M., Woodworth R.C., Mason A.B., He Q.Y. (2004) “The low pKa value of iron-binding ligand tyr188 and its implication in iron release and anion binding of human transferrin”  FEBS Letters, 573(1-3), 181-185. doi: 10.1016/j.febslet.2004.07.076.

  3. Li H.Y., Li F., Qian Z.M., Sun H.Z.* (2004) “Structure and topology of the transmembrane domain 4 of the divalent metal transporter in membrane-mimetic environments” European Journal of Biochemistry, 271(10), 1938-1951. doi: 10.1111/j.1432-1033.2004.04104.x.

  4. Sun H.Z.*, Zhang L., Szeto K.Y. (2004) “Bismuth in medicine” Metal Ions in Biological System, 41, 333-378. (Featured on the cover of the issue)

  5. Li F., Sun H.Z.* “Dynamic and kinetic aspects of metallodrugs by NMR” in Fluxional Organometallic and Coordination Chemistry (Edited by Gielen M., Willem R., Wrackmeyer B.), John-Wiley & Sons, 163-217, 2004. doi: 10.1002/0470858451.ch5.

  6. Jin L., Szeto K.Y., Zhang L., Du W.H., Sun H.Z.* (2004) “Inhibition of alcohol dehydrogenase by bismuth” Journal of Inorganic Biochemistry, 98(8), 1331-1337. doi: 10.1016/j.jinorgbio.2004.03.016.

  7. Liu C.L., Wang M., Zhang T.L., Sun H.Z. (2004) “DNA hydrolysis promoted by di- and multi-nuclear metal complexes” Coordination Chemistry Reviews, 248(1-2), 147-168. doi: 10.1016/j.cct.2003.11.002.

​

2003

  1. Zheng Q., Yang W.M., Yu W.H., Cai B., Teng X.C., Yi X., Sun H.Z., Zhang M.J., Huang Z.X. (2003) “The effect of EAAEAE insert on property of human metallothionein-3” Protein Engineering, 16(12), 865-870. doi: 10.1093/protein/gzg127.

  2. Li W., Jin L., Zhu N.Y., Hou X.M., Deng F., Sun H.Z.* (2003) “Structure of colloidal bismuth subcitrate in dilute HCl:  assembly of dinuclear [Bi(cit)2Bi]2-” Journal of the American Chemical Society, 125(41), 12408-12409. doi: 10.1021/ja037019x.

  3. Li H.Y., Li F., Sun H.Z.*, Qian Z.M. (2003) “Membrane-inserted conformation of transmembrane domain4 of divalent metal transporter” Biochemical Journal, 372(Pt 3), 757-766. doi: 10.1042/bj20030075.

  4. Yan S.C., Li F., Ding K.Y., Sun H.Z.* (2003) “Reduction of pentavalent antimony and formation of binary and ternary complex with trypanothione” Journal of Biological Inorganic Chemistry, 8(6), 689-697. doi: 10.1007/s00775-003-0468-1.

  5. Sun H.Z.*, Szeto K.Y. (2003) “Binding of bismuth to serum proteins: implication for targets of Bi(III) in blood plasma”. Journal of Inorganic Biochemistry, 94(1-2), 114-120. doi: 10.1016/S0162-0134(02)00649-9.

  6. Che C.-M.*, Sun R.W.Y., Yu W.Y., Ko B.C.B., Zhu N.Y., Sun H.Z.* (2003) “Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells” Chemical Communications, (14), 1718-1719. doi: 10.1039/B303294A.

  7. Lo W.Y., Lam C.H., Fung W.K.M., Sun H.Z., Yam V.W.W., Balcells D., Maseras F., Eisenstein O. (2003) “An oscillating C22- unit inside a copper rectangle” Chemical Communications, (11), 1260-1261. doi: 10.1039/B301842C.

  8. Yan S.C., Wong L.K., Chow L.M.C., Sun H.Z.* (2003) “Rapid reduction of pentavalent antimony by trypanothione: potential relevance to antimonial activation” Chemical Communications, (2), 266-267. doi: 10.1039/B210240D.

​

2002

  1. Du X.L., Zhang T.L., Yuan L., Zhao Y.Y., Li R.C., Wang K., Yan S.C., Zhang L., Sun H.Z. Qian Z.M. (2002) “Complexation of ytterbium to human transferrin and its uptake by K562 cells” European Journal of Biochemistry, 269(24), 6082-6090. doi: 10.1046/j.1432-1033.2002.03326.x.

  2. Sun H.Z.* (2002) “Metallodrugs” in Encyclopedia of Nuclear Magnetic Resonance: Advances in NMR (Ed: Grant, D.M. & Harris R.K., John Wiley & Sons Ltd.), 413-427.

  3. Li H.Y., Sun H.Z., Qian Z.M. (2002) “Drug delivery and targeting: the role of transferrin/transferrin receptor system” Trends in Pharmacological Sciences, 23(5), 206-209. doi: 10.1016/S0165-6147(02)01989-2.

  4. Sun H.Z.*, Zhang L., Szeto K.Y. (2002) “Basis of bismuth antiulcers: biological chemistry and pharmacology”. Chinese Journal of Clinical Pharmacology, 18, 297-301. doi: 10.3969/j.issn.1001-6821.2002.04.015.

  5. Zhang R., Yu W.Y., Sun H.Z., Liu W.S., Che C.M. (2002) “Stereo- and enantioselective alkene epoxidations: a comparative study of D4- and D2-symmetric homochiral trans-dioxoruthenium(VI) porphyrins” Chemistry, A European Journal, 8(11), 2495-2507. doi: 10.1002/1521-3765(20020603)8:11<2495::AID-CHEM2495>3.0.CO;2-G.

  6. Qian Z.M., Li H.Y., Sun H.Z., Ho K. (2002) “Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway” Pharmacological Reviews, 54(4), 561-587. doi: 10.1124/pr.54.4.561. (Featured on the cover of the issue)

​

2001

  1. Zhang L., Szeto K.Y., Wong W.B., Sadler P.J., Sun H.Z.* (2001) “Interactions of bismuth with human lactoferrin and recognition of Bi(III)-lactoferrin by intestinal cells” Biochemistry, 40(44), 13281-13287. doi: 10.1021/bi010579t.

  2. Sun H.Z., Li H.Y., Mason A.B., Woodworth R.C., Sadler P.J. (2001) “Competitive binding of bismuth to transferrin and albumin in aqueous solution and blood plasma” Journal of Biological Chemistry, 276(12), 8829-8835. doi: 10.1074/jbc.M004779200.

​

2000​

  1. Sun H.Z.*, Yan S.-C., Cheng W.-S. (2000) “Interaction of antimony tartrate with the tripeptide glutathione: implication for its mode of action” European Journal of Biochemistry, 267(17), 5450-5457. doi: 10.1046/j.1432-1327.2000.01605.x.

  2. Yan S.C., Ding K., Zhang L., Sun H.Z.* (2000) “Complexation of antimony(III) to trypanothione” Angewandte Chemie International Edition, 39(23), 4260-4262. doi: 10.1002/1521-3773(20001201)39:23<4260::AID-ANIE4260>3.0.CO;2-9.

  3. Guo M.L., Sun H.Z., McArdle H. J., Gambling L., Sadler P. J. (2000) “TiIV uptake and release by human serum transferrin and recognition of TiIV-transferrin by cancer cells: understanding the mechanism of the anticancer agent titanocene dichloride” Biochemistry, 39(33), 10023-10033. doi: 10.1021/bi000798z.

  4. Guo M.L., Sun H.Z., Bihari S., Parkinson J.A., Gould R.O., Parsons S., Sadler P.J. (2000) “Stereoselective formation of seven-coordinate titanium(IV) monomer and dimer complexes of ethylenebis(o-hydroxyphenyl)glycine” Inorganic Chemistry, 39(2), 206-215. ​doi: 10.1021/ic990669a.

​

bottom of page